Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion.
We previously described mouse hepatitis virus (MHV) variant V51 derived from a persistent infection of murine DBT cells with an expanded host range (R. S. Baric, E. Sullivan, L. Hensley, B. Yount, and W. Chen, J. Virol. 73:638-649, 1999). Sequencing of the V51 spike gene, the mediator of virus entry, revealed 13 amino acid substitutions relative to the originating MHV A59 strain. Seven substitutions were located in the amino-terminal S1 cleavage subunit, and six were located in the carboxy-terminal S2 cleavage subunit. Using targeted RNA recombination, we constructed a panel of recombinant viruses to map the mediators of host range to the six substitutions in S2, with a subgroup of four changes of particular interest. This subgroup maps to two previously identified domains within S2, a putative fusion peptide and a heptad repeat, both conserved features of class I fusion proteins. In addition to an altered host range, V51 displayed altered utilization of CEACAM1a, the high-affinity receptor for A59. Interestingly, a recombinant with S1 from A59 and S2 from V51 was severely debilitated in its ability to productively infect cells via CEACAM1a, while the inverse recombinant was not. This result suggests that the S2 substitutions exert powerful effects on the fusion trigger that normally passes from S1 to S2. These novel findings play against the existing data that suggest that MHV host range determinants are located in the S1 subunit, which harbors the receptor binding domain, or involve coordinating changes in both S1 and S2. Mounting evidence also suggests that the class I fusion mechanism may possess some innate plasticity that regulates viral host range.
McRoy
Willie C
WC
University of North Carolina at Chapel Hill, 2107 McGavran Greenberg Hall, CB 7435, Chapel Hill, NC 27599-7435, USA.
Baric
Ralph S
RS
D019943:Amino Acid Substitution / Q000235:genetics*; D000818:Animals; D002272:Carcinoembryonic Antigen / Q000378:metabolism; D002415:Cats; D002460:Cell Line; D006224:Cricetinae; D003412:Cricetulus; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics / Q000502:physiology*; D051379:Mice; D006517:Murine hepatitis virus / Q000235:genetics / Q000502:physiology*; D064370:Spike Glycoprotein, Coronavirus; D013552:Swine; D014759:Viral Envelope Proteins / Q000235:genetics / Q000502:physiology*; D053586:Virus Internalization
D002272:Carcinoembryonic Antigen; C486183:Ceacam1 protein, mouse; D008562:Membrane Glycoproteins; D064370:Spike Glycoprotein, Coronavirus; D014759:Viral Envelope Proteins